Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM2 | O94759 | 3/20 | 0.62 |
| ▸ | MMP1 | P03956 | 9/20 | 0.60 |
| ▸ | MMP2 | P08253 | 9/20 | 0.60 |
| ▸ | MMP9 | P14780 | 9/20 | 0.60 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.59 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.58 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.58 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | PELI1 | Q96FA3 | 1/20 | 0.53 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5351229 | 1.00 | TRPM2 (0.62) | TRPM2MMP1MMP2MMP9LTB4R | |
| SCHEMBL29913807 | 1.00 | TRPM2 (0.62) | TRPM2MMP1MMP2MMP9LTB4R | |
| SCHEMBL6013326 | 0.93 | TRPM2 (0.64) | TRPM2MMP1MMP2MMP9LTB4R | |
| SCHEMBL4670106 | 0.93 | TRPM2 (0.64) | TRPM2MMP1MMP2MMP9LTB4R | |
| SCHEMBL18230842 | 0.92 | TRPM2 (0.64) | TRPM2MMP1MMP2MMP9LTB4R | |
| SCHEMBL25144814 | 0.90 | TRPM2 (0.52) | TRPM2MMP1MMP2MMP9LTB4R | |
| SCHEMBL9973825 | 0.90 | TRPM2 (0.62) | TRPM2MMP1MMP2MMP9LTB4R | |
| SCHEMBL4199528 | 0.89 | MMP1 (0.64) | TRPM2MMP1MMP2MMP9TRPA1 | |
| SCHEMBL30041332 | 0.89 | MMP1 (0.64) | TRPM2MMP1MMP2MMP9TRPA1 | |
| SCHEMBL4199523 | 0.89 | MMP1 (0.64) | TRPM2MMP1MMP2MMP9TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | SYMRISE AG (DE) | 2026-03-03 | — | — | US | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| EP-4487838-A2 | AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY COMPRISING 4-HYDROXYPHENONE | Symrise AG (DE) | 2025-01-08 | — | — | EP | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| EP-4114354-B1 | AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY COMPRISING 4-HYDROXYPHENONE | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | claimed |
| CN-117814312-A | Milk beverage capable of loading different types of polyphenols and preparation method thereof | 江苏大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117257663-A | Avena sativa alkaloid A, B, C composition and application thereof in preparing cosmetic skin soothing agent | 福州美乐莲生物科技有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-117099955-A | Different pKs can be loaded a Aqueous casein solution of polyphenol and preparation method thereof | 江苏大学 | 2023-11-24 | — | — | CN | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| EP-4125984-A1 | A CONSUMABLE PRODUCT COMPRISING MALTED CEREALS FOR PROMOTING RECOVERY AT PHYSICAL ACTIVITY | Lantmännen Functional Foods AB (SE) | 2023-02-08 | — | — | EP | claimed |
| CN-115605214-A | Consumable product comprising malted cereals for promoting recovery of physical activity | 兰特门内保健食品公司（SE） | 2023-01-13 | — | — | CN | claimed |
| EP-4114349-A1 | COMPOSITION OR OAT EXTRACT COMPRISING AVENANTHRAMIDE AND BETA-GLUCAN | Symrise AG (DE) | 2023-01-11 | — | — | EP | claimed |
| EP-4114354-A1 | AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY COMPRISING 4-HYDROXYPHENONE | Symrise AG (DE) | 2023-01-11 | — | — | EP | claimed |
| CN-115554370-A | Composition for improving autoimmune thyroiditis and application thereof | 陕西中鸿科瑞再生医学研究院有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-115243669-A | Avenanthramide compositions with enhanced solubility comprising 4-hydroxybenzophenones | 西姆莱斯股份公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115243670-A | Cosmetic or pharmaceutical use of avenanthramide L | 西姆莱斯股份公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115209864-A | Compositions comprising avenanthramides or analogs thereof having improved stability | 西姆莱斯股份公司 | 2022-10-18 | — | — | CN | claimed |
| EP-3113754-B1 | OXIDATIVE HAIR DYEING COMPOSITION | KAO GERMANY GMBH (DE) | 2022-07-27 | — | — | EP | claimed |
| WO-2022128052-A1 | MEDICAMENT FOR FIGHTING INFLAMMATORY CONDITIONS OF HUMAN SKIN | SYMRISE AG (DE) | 2022-06-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | CUTA, HLA-A, OAT | TRPM2 962/4885MMP1 2429/4885MMP2 3268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.